Transitional care in IBD: Who is it for, and how should we do this?

In this video, Vikas Majithia, MD, talks about how the COVID-19 pandemic has affected the treatment of autoimmune patients at his practice in Mississippi.

Larry Smarr, Founding Director, CALIT2, details the growing epidemic of children, especially those with gastrointestinal disorders, who were not exposed to the necessary microbiomes during the formative...